Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3765446
Max Phase: Preclinical
Molecular Formula: C13H21NO4
Molecular Weight: 255.31
Molecule Type: Small molecule
Associated Items:
ID: ALA3765446
Max Phase: Preclinical
Molecular Formula: C13H21NO4
Molecular Weight: 255.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C(C)[C@@H](O)[C@H](C)C(=O)N1C(=O)OC[C@@H]1C(C)C
Standard InChI: InChI=1S/C13H21NO4/c1-7(2)10-6-18-13(17)14(10)12(16)9(5)11(15)8(3)4/h7,9-11,15H,3,6H2,1-2,4-5H3/t9-,10+,11+/m0/s1
Standard InChI Key: MKCFRAZLNSLMQZ-HBNTYKKESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 255.31 | Molecular Weight (Monoisotopic): 255.1471 | AlogP: 1.56 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 1.93 | CX LogD: 1.93 |
Aromatic Rings: 0 | Heavy Atoms: 18 | QED Weighted: 0.77 | Np Likeness Score: 1.09 |
1. Singh S, Gajulapati V, Gajulapati K, Goo JI, Park YH, Jung HY, Lee SY, Choi JH, Kim YK, Lee K, Heo TH, Choi Y.. (2016) Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers., 26 (4): [PMID:26810262] [10.1016/j.bmcl.2016.01.016] |
Source(1):